Skip to content

Regulatory Considerations Expert Group reviews draft FDA Guidance

Date: June 19, 2023

The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on the recent draft FDA Guidance: Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations Questions and Answers.

The guidance provides an overall overview about the most relevant key points to consider on the use of electronic systems, electronic records and electronic signatures in clinical investigations. It also provides recommendations regarding the requirements, under 21 CFR part 11, under which FDA considers electronic systems, electronic records, and electronic signatures to be trustworthy, reliable, and generally equivalent to paper records and handwritten signatures executed on paper.

This guidance has been open for public consultation and the Regulatory Considerations Expert Group have provided feedback to the FDA on some points that may need further clarity, on behalf of the ACDM. The final guidance is expected to be released once the FDA have reviewed and agreed on implementation feedback received for the whole international clinical trials community.

The ACDM Regulatory Considerations Expert Group looks at providing guidance information on a number of areas surrounding regulations. If you are interested in joining, find out more here: https://acdmglobal.org/regulatory-considerations-dmeg/

 


 

Explore More News

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda

Tamer Chowdhury, on behalf of ACDM Technology DMEG. On April 28, FDA Commissioner Dr. . . .

Read More

Bridging the Behaviour Gap: The Human Skills Redefining Clinical Data Management (ACDM26 Workshop Recap)

This article has been written by Gail Kniveton, who delivered the workshop “Bridging the . . .

Read More

Regulatory Considerations DMEG reviews recent MHRA regulatory updates

The ACDM Regulatory considerations DMEG Regulatory considerations reviewed several recent . . .

Read More

ACDM26 Berlin: Shaping the Future of Clinical Data Management

The ACDM Annual Conference returned to Berlin in March 2026, welcoming the global clinical . . .

Read More

Member News Update from Lab Data Solutions LLC

This news piece has been submitted by Lab Data Solutions LLC We’re Attending US Summit . . .

Read More

Welcome Veramed as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome Veramed as a . . .

Read More

Welcome CROss Alliance as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome CROss Alliance . . .

Read More

Regulatory Considerations DMEG Update

With mixed feelings, we share that Silvia Pérez Torres, current chair of the ACDM . . .

Read More

Newsletter Committee’s Christmas Copilot Tips

In a time when we are constantly surrounded by artificial intelligence and feel the need . . .

Read More

Welcome Data Magik as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome Data Magik as . . .

Read More

Welcome The Institute of Cancer Research – Scientific Computing as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome The Institute . . .

Read More

Newsletter Committee: Meet Federica

The ACDM is delighted to welcome Federica Migliore of IQVIA to the Newsletter . . .

Read More